Researchers has demonstrably boosted its development of a new treatment for amyloid heart disease, leveraging the compound. Preliminary clinical results suggests promising outcomes for those diagnosed with the severe https://biotech054179.digiblogbox.com/66529208/bridgebio-progresses-cardiac-amyloidosis-management-with-the-drug